Sequentify
PrivateLast Round
Grant
Jan 11, 2024
Total Funding Raised
$7M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Sequentify operates in Healthcare & Life Sciences and is based in Israel. Its latest recorded funding round was a Grant round in January 2024.
Sequentify is a biotechnology company that provides library-preparation solutions and AI software for next-generation sequencing to enable faster and more cost-effective genomic testing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sequentify Comparables
Compare Sequentify with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Micronbrane Medical | 79% | |
| SeqWell | 79% | |
| Quantabio | 76% |
For institutional investors. Book with your work email.
Sequentify Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 11, 2024 | ||||
| Seed | May 10, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Sequentify Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Israel Innovation Authority | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 226% MoM, reaching 2K.
- Jul 31, 2025
Appointed Dr. Ravi Majeti, an expert in hematologic malignancies.
For institutional investors. Book with your work email.
Sequentify Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sequentify's valuation, stock price, and market status.
Is Sequentify a public or private company?
Sequentify is a private company.
What is the current stock price of Sequentify?
Sequentify is a private company, so its shares have no public market price. Caplight tracks Sequentify's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sequentify worth (valuation)?
Valuation information for Sequentify is not publicly available.
Can I buy Sequentify stock?
Sequentify shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sequentify's last funding round?
Sequentify's most recent funding round was Grant on January 11, 2024.
Who are the main investors in Sequentify?
Key investors in Sequentify include Israel Innovation Authority.
Will Sequentify IPO soon?
No public IPO plans have been announced for Sequentify.
How can I track Sequentify secondary market activity?
Caplight tracks bids, offers, and trades in Sequentify's shares on secondary markets.